Skip to main content
An official website of the United States government

anti-CD19 monoclonal antibody MDX-1342

A fully human anti-CD19 monoclonal antibody directed against the B-cell-specific membrane protein CD-19 with potential antineoplastic activity. Anti-CD19 monoclonal antibody MDX-1342 binds to CD19, depleting and eliminating CD19-expressing B cells. CD19 is widely expressed during B-cell development, from pro-B-cell to early plasma cell stages.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Code name:MDX-1342
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search